放射性引导前哨淋巴结活检在临床N0期BRAF V600E突变小型甲状腺乳头状癌中的初步研究
该初步研究纳入15例超声提示N0且术前活检BRAF V600E突变的甲状腺乳头状癌患者,比较常规手术与加做放射性引导前哨淋巴结活检(SNB)的效果。SNB在10例中检出4例微转移,平均随访53个月无复发,提示SNB可准确分期并可能减少预防性颈清扫。
要点
- SNB在10例中检出4例微转移,中央区3/6、同侧侧颈2/6、对侧0/2。
- 平均随访53个月,全部患者无复发记录。
- SNB可能限制耗时且增加风险的预防性分区清扫。
核心结论
- 放射性引导SNB能正确且有效地对cN0 BRAF突变甲状腺乳头状癌进行分期。
- SNB可能限制耗时且增加风险的预防性分区清扫。
研究设计与样本
- 初步研究分析15例超声N0且术前活检BRAF突变的甲状腺乳头状癌患者。
- 患者接受全甲状腺切除或全甲状腺切除加预防性中央颈清扫,单独或加SNB;常规手术在SNB前完成。
主要发现
- 15例中5例仅常规手术(4例全甲状腺切除,1例全甲状腺切除加预防性中央颈清扫),10例加SNB。
- SNB组中1例未检出前哨淋巴结而仅行全甲状腺切除,2例在全甲状腺切除加预防性中央颈清扫基础上行侧区SNB,7例在全甲状腺切除基础上行1至3个颈区SNB。
- 预防性中央颈清扫标本3例中1例发现微转移;SNB在中央区6例中3例、同侧侧区6例中2例、对侧区2例中0例发现转移。
- SNB使10例中4例的微转移得以切除。
- 平均随访53个月,未记录到复发。
临床怎么用
- 对超声cN0且BRAF V600E突变的甲状腺乳头状癌,可考虑放射性引导SNB以准确分期并指导是否需分区清扫。
局限性
- 原文为初步研究,样本量仅15例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: BRAF V600E mutation papillary thyroid cancer (PTC) is more aggressive with a higher risk of lymph node involvement and a poorer prognosis. Prior studies failed to demonstrate the superiority of prophylactic lymphadenectomy. We investigated the utility of additional radio-guided sentinel node biopsy (SNB). METHODS: We analyzed 15 patients with N0 PTC by ultrasound and BRAF mutation on preoperative biopsy treated with total thyroidectomy (TT) or TT + prophylactic central neck dissection (PCND) alone or with SNB. Conventional surgery was performed before SNB. We recorded primary tumor diameter, multifocality, extrathyroid infiltration, neoplastic emboli, and tall cell variant. At follow-up, we evaluated basal and stimulated thyroglobulin and ultrasound or radioiodine scintigraphy. RESULTS: Of 15 consecutive patients, 5 received conventional surgery alone, and 10 had SNB. For the first group, 4 underwent TT, and 1 had TT + PCND. Among the SNB group, 1 had no sentinel node detected and underwent a simple TT, 2 had TT + PCND+ SNB in the lateral compartment, and 7 had TT + SNB in 1 to 3 neck compartments. Micrometastases were found in 1 of 3 PCND specimens. Sentinel node biopsy revealed metastasis in 3 of 6 central compartment biopsies, in 2 of 6 biopsies in the ipsilateral lateral compartment, and in none of 2 biopsies in the contralateral compartment. Sentinel node biopsy allowed the removal of micrometastases in 4 of 10 patients. At 53 months' (mean) follow-up, no relapse was documented. CONCLUSIONS: Radio-guided SNB correctly and efficiently stages cN0 BRAF-mutated PTC patients. Sentinel node biopsy could limit time-consuming, risk-exposing compartmental prophylactic dissections.
引用
- Puccini M, Manca G, Neri CM, et al. Effect of Sentinel Node Biopsy in Clinically N0, BRAF V600E-Mutated, Small Papillary Thyroid Carcinoma: A Pilot Study. Clin Nucl Med. 2019. PMID: 30688735. doi:10.1097/RLU.0000000000002465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。